Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Osanto, Susanne ^a   Qin, Yongjun ^a   Buermans, Henk P ^a   Berkers, Johannes ^b   Lerut, Evelyne ^b   Goeman, Jelle J ^a   van Poppel, Hendrik ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; KIDNEY CARCINOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PROGNOSIS; RNA ANALYSIS; RNA SEQUENCE; UPREGULATION; VALIDITY;

CARCINOMA, RENAL CELL; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862701358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038298     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66. 57/1/43 [pii].
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, et al. (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592 mdl498 [pii];10.1093/annonc/mdl498 [doi].
3. Rini BI, Rathmell WK, Godley P, (2008) Renal cell carcinoma. Curr Opin Oncol 20: 300-306 10.1097/CCO.0b013e3282f9782b [doi];00001622-200805000-00011 [pii].
4. Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ, (2011) Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int 10.1111/j.1464-410X.2011.10629.x [doi].
5. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269 nrc1840 [pii];10.1038/nrc1840 [doi].
7. Bushati N, Cohen SM, (2007) microRNA functions. Annu Rev Cell Dev Biol 23: 175-205 10.1146/annurev.cellbio.23.090506.123406 [doi].
8. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714 nrg2634 [pii];10.1038/nrg2634 [doi].
9. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427 10.1002/path.2437 [doi].
10. Huang Y, Dai Y, Yang J, Chen T, Yin Y, et al. (2009) Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol 35: 1119-1123 S0748-7983(09)00140-1 [pii];10.1016/j.ejso.2009.04.010 [doi].
11. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, et al. (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928 JCMM705 [pii];10.1111/j.1582-4934.2009.00705.x [doi].
12. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, et al. (2009) MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35: 109-114.
13. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, et al. (2010) Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158 S0009-9120(09)00319-1 [pii];10.1016/j.clinbiochem.2009.07.020 [doi].
14. Fridman E, Dotan Z, Barshack I, David MB, Dov A, et al. (2010) Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12: 687-696 S1525-1578(10)60114-6 [pii];10.2353/jmoldx.2010.090187 [doi].
15. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, et al. (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841 S0090-4295(09)02809-X [pii];10.1016/j.urology.2009.10.033 [doi].
16. Weng L, Wu X, Gao H, Mu B, Li X, et al. (2010) MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 222: 41-51 10.1002/path.2736 [doi].
17. Youssef YM, White NM, Grigull J, Krizova A, Samy C, et al. (2011) Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature. Eur Urol 59: 721-730 S0302-2838(11)00009-1 [pii];10.1016/j.eururo.2011.01.004 [doi].
18. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, et al. (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867 S1097-2765(09)00634-0 [pii];10.1016/j.molcel.2009.09.006 [doi].
19. Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, et al. (2010) The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol 183: 743-751 S0022-5347(09)02627-5 [pii];10.1016/j.juro.2009.09.086 [doi].
20. Krichevsky AM, Gabriely G, (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39-53 JCMM556 [pii];10.1111/j.1582-4934.2008.00556.x [doi].
21. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, et al. (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76: 582-588 S0006-2952(08)00387-0 [pii];10.1016/j.bcp.2008.06.007 [doi].
22. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, et al. (2008) hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348 14/5/1340 [pii];10.1158/1078-0432.CCR-07-1755 [doi].
23. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, et al. (2010) hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116: 2148-2158 10.1002/cncr.25009 [doi].
24. Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, et al. (2011) MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286: 420-428 M110.170852 [pii];10.1074/jbc.M110.170852 [doi].
25. Li Z, Hu S, Wang J, Cai J, Xiao L, et al. (2010) MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol 119: 125-130 S0090-8258(10)00431-2 [pii];10.1016/j.ygyno.2010.06.004 [doi].
26. White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, et al. (2010) Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biol Chem 391: 411-423 10.1515/BC.2010.041 [doi].
27. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, et al. (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282: 23716-23724 M701805200 [pii];10.1074/jbc.M701805200 [doi].
28. Lai KW, Koh KX, Loh M, Tada K, Subramaniam MM, et al. (2010) MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 46: 1456-1463 S0959-8049(10)00084-5 [pii];10.1016/j.ejca.2010.01.036 [doi].
29. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med jem.20101823 [pii];10.1084/jem.20101823 [doi].
30. Lee Y, Yang X, Huang Y, Fan H, Zhang Q, et al. (2010) Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 6 10.1371/journal.pcbi.1000730 [doi].
31. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, et al. (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208: 535-548 jem.20101812 [pii];10.1084/jem.20101812 [doi].
32. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, et al. (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97: 1663-1671 10.1002/cncr.11234 [doi].
33. Buermans HP, Ariyurek Y, van OG, den Dunnen JT, t Hoen PA, (2010) New methods for next generation sequencing based microRNA expression profiling. BMC Genomics 11 1471-2164-11-716 [pii];10.1186/1471-2164-11-716 [doi].
34. Robinson MD, McCarthy DJ, Smyth GK, (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140 btp616 [pii];10.1093/bioinformatics/btp616 [doi].
35. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-300.
36. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408 10.1006/meth.2001.1262 [doi];S1046-2023(01)91262-9 [pii].
37. Qin Y, Verdegaal EM, Siderius M, Bebelman JP, Smit MJ, et al. (2011) Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell Melanoma Res 24: 207-218 10.1111/j.1755-148X.2010.00781.x [doi].
38. Kadri S, Hinman V, Benos PV, (2009) HHMMiR: efficient de novo prediction of microRNAs using hierarchical hidden Markov models. BMC Bioinformatics 10 (Suppl 1) 1471-2105-10-S1-S35 [pii];10.1186/1471-2105-10-S1-S35 [doi].